M77.1
Conditions
Interventions
Group 1: ACP-therapy (Autologous Conditioned Plasma): The patients received three injections with an interval of seven days. ACP Double Syringe System by Arthrex (Arthrex, Inc. Naples, Florida, USA)
Sponsors
Orthopädie, Universitätsklinikum Magdeburg
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Clinically diagnosed epicondylitis with minimum of three month of pain with previously unsuccessful conservative treatment
Exclusion criteria
Exclusion criteria: Local injections in the last month in the region of the epicondyle, Laser treatment to the affected arm previously, Evidence of disordered pain perception, Pregnancy, Rheumatic diseases, Systemic-inflammatory diseases, Hemato-oncological diseases with low platelet numbers, Infectious diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The detected parameters were a visual analogue scale (VAS) for pain with a range from 0 (no pain) to 10 (most severe pain), as well as the Disabilities of arm, shoulder and hand (DASH) questionnaire. The control examinations were conducted before therapy, after two month, six month and after one year. | — |
Secondary
| Measure | Time frame |
|---|---|
| Additionally examination of the elbow, of limitations in extension movements and demographic data (age, gender, job, freetime activity) were evaluated before treatment, after two, six and 12 month. | — |
Countries
Germany
Contacts
Public ContactElisa Tetschke
Orthopädische Klinik des Universitätsklinikums Magdeburg
Outcome results
None listed